期 |
栏目 |
标题 |
文件 |
卷 15, 编号 6 (2018) |
Articles |
About the role of bacteria in patients with bronchial asthma, chronic obstructive pulmonary disease and ACOS |
|
卷 15, 编号 2 (2018) |
Articles |
What is аsthma-COPD Overlap syndrome (ACOS), diagnostics and treatment |
|
卷 14, 编号 6 (2017) |
Articles |
THE FUNCTIONAL STATUS OF NEUTROPHILS IN PATIENTS WITH BRONCHIAL ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BRONCHIAL ASTHMA IN COMBINATION WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND COMMUNITY-ACOUIRED PNEUMONIA |
|
卷 13, 编号 6 (2016) |
Articles |
Regarding to the issue of the role of cytokines in the pathogenesis of asthma and the possibilities of anticytokine therapy |
(Rus)
|
卷 12, 编号 6 (2015) |
Articles |
Infectious and noninfectious sensibilization of patients with bronchial asthma and chronic obstructive pulmonary disease |
|
卷 12, 编号 2 (2015) |
Articles |
Markers of endothelial dysfunction in bronchial asthma patients |
|
卷 12, 编号 1 (2015) |
Articles |
Sputum characteristics and evaluation of airways inflammation peculiarities in patients with bronchial asthma and chronic obstructive pulmonary disease |
|
卷 11, 编号 2 (2014) |
Articles |
Peculiarities of inflammatory process and markers of inflammation in patients with bronchial asthma and COPD |
|
卷 10, 编号 2 (2013) |
Articles |
Expired air nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease with different disease course |
|
卷 9, 编号 2 (2012) |
Articles |
MUTATION C3435T IN MULTI-DRUG RESISTANCE GENE MDR1 AS PHARMACOGENETIC MARKER OF SEVERE COURSE OF BRONCHIAL ASTHMA |
|
卷 8, 编号 5 (2011) |
Articles |
Effect of t reat ment of parasite s a nd inte stinaldisbiosis in t he c ourse of a sthma |
|
卷 9, 编号 1 (2012) |
Articles |
Multiple faces of bronchial asthma - phenotypes and clinical pathogenetic variants |
|
卷 6, 编号 3 (2009) |
Articles |
Psychosomatic aspects of bronchial asthma: mechanisms of development, peculiarities of diagnostics, clinical manifestations and treatment |
|
卷 7, 编号 3 (2010) |
Articles |
Multidrug resistance gene (MDR1) - marker of therapeutic resistance and severity of disease |
|